Medical Technology - Suriname

  • Suriname
  • Suriname is expected to see a significant rise in revenue within the Medical Technology market market.
  • By 2024, the projected revenue is estimated to reach US$38.92m.
  • The largest market within this market is Medical Devices, which is projected to have a market volume of US$33.20m in 2024.
  • Over the period of 2024-2029, the revenue is anticipated to grow at an annual rate of 9.42%, resulting in a market volume of US$61.05m by 2029.
  • When compared globally, the United States is expected to generate the highest revenue, reaching US$211.10bn in 2024.
  • Suriname's medical technology market is experiencing a surge in demand for advanced diagnostic imaging equipment.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in Suriname is experiencing steady growth due to several factors. Customer preferences in Suriname are shifting towards more advanced and innovative medical technologies, which is driving the demand for such products in the market. Additionally, local special circumstances and underlying macroeconomic factors are also contributing to the development of the Medical Technology market in Suriname. Customer preferences in Suriname are increasingly focused on accessing high-quality healthcare services and advanced medical technologies. Patients in Suriname are becoming more aware of the latest medical advancements and are seeking out treatments and technologies that can provide better outcomes. This growing demand for advanced medical technologies is driving the growth of the Medical Technology market in Suriname. Trends in the market indicate a shift towards the adoption of digital health technologies in Suriname. Telemedicine and remote patient monitoring are gaining popularity as they allow patients to access healthcare services from the comfort of their homes. This trend is particularly relevant in Suriname, where access to healthcare facilities in remote areas can be challenging. The use of digital health technologies not only improves access to healthcare but also enhances the efficiency and effectiveness of medical treatments. Local special circumstances in Suriname, such as an aging population and a rising burden of chronic diseases, are also contributing to the growth of the Medical Technology market. As the population ages, the demand for medical devices and technologies that can diagnose and treat age-related conditions is increasing. Similarly, the rising prevalence of chronic diseases, such as diabetes and cardiovascular diseases, is driving the demand for medical technologies that can effectively manage these conditions. Underlying macroeconomic factors, such as increasing healthcare expenditure and government initiatives to improve healthcare infrastructure, are further fueling the growth of the Medical Technology market in Suriname. The government of Suriname has been investing in the healthcare sector to improve access to quality healthcare services, which includes the procurement of advanced medical technologies. This investment is creating opportunities for medical technology companies to expand their presence in the market. In conclusion, the Medical Technology market in Suriname is experiencing growth due to customer preferences for advanced medical technologies, the adoption of digital health technologies, local special circumstances such as an aging population and rising chronic diseases, and underlying macroeconomic factors such as increased healthcare expenditure and government initiatives. These factors collectively contribute to the development and expansion of the Medical Technology market in Suriname.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)